期刊文献+

钙离子拮抗剂尼伐地平的波谱学解析与结构确证 被引量:1

Spectral analysis and structural elucidation of calcium antagonist nilvadipine
下载PDF
导出
摘要 目的对钙离子拮抗剂尼伐地平进行系统的波谱学解析与结构确证。方法运用热分析、圆二色谱、紫外光谱、红外光谱、核磁共振、质谱、高分辨率质谱以及X射线粉末衍射等分析手段测定样品的谱学数据,并进行系统解析与归属。结果证实尼伐地平的结构为3-甲基-5-(1-甲基乙基)-4-(RS)-2-氰基-6-甲基-4-(3-硝基苯基)-1,4-二氢吡啶-3,5-二羧酸酯。结论本法测定结果准确,为尼伐地平的生产和鉴定提供较为全面的参考数据。 Objective To determine the chemical structure of nilvadipine with systematic spectrum analysis. Methods TG-DSC, CD, UV, FT-IR, NMR, MS, HRMS, and XRD were adopted to analyze the chemical structure of Nilvadipine. Results The structure of nilvadipine was 3-methyl-5-(1-methylethyl)-4-(RS)-2-cyano-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3, 5-dicarboxylate. Conclusion This result is accurate and can provide a comprehensive reference for production and identification of nilvadipine.
出处 《中南药学》 CAS 2014年第4期333-336,共4页 Central South Pharmacy
关键词 钙离子拮抗剂 尼伐地平 结构分析 calcium antagonist nilvadipine structure analysis
  • 相关文献

参考文献12

  • 1岳步星.新型钙通道拮抗剂及伐地平[J].国外医药(合成药.生化药.制剂分册),1996,17(1):27-29. 被引量:1
  • 2Leonetti G.Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension:a double blind,prospective,randomised clinical trial[J].Curr Med Res Opin,2005,21(6):951-958.
  • 3Satoh Y,Ichihashi M,Okumura K,et al.Studies on nilvadipine.I.Synthesis and structure-activity relationships of 1,4-dihydropyridines containing novel substituents at the 2-position[J].Chemi&Pharm Bull,1991,39(12):3189-3201.
  • 4Brogden RN,McTavish D.Nilvadipine:a review of its pharmacodynamic and pharmacokinetic properties,therapeutic use in hypertension and potential in cerebrovascular disease and angina[J].Drugs&Aging,1995,6(2):150-171.
  • 5陈波,赵兰芳,喻凯,谭桂山,徐康平.顶空气相色谱法测定尼伐地平中的残留溶剂[J].中南药学,2013,11(5):385-387. 被引量:7
  • 6Motiwala F,Ojike N,Lippmann S.Dihydropyridine calcium channel blockers in dementia and hypertension[J].Curr Psych Rep,2013,12(8):41.
  • 7Kennelly S,Abdullah L,Kennyl RA,et al.Apolipoprotein E genotype-specifi c short-term cognitive benefi ts of treatment with the antihypertensive nilvadipine in Alzheimer’s patientsan open-label trial[J].Int J Geriatr Psych,2012,27(4):415-422.
  • 8Kennelly SP,Abdullah L,Paris D,et al.Demonstration of safety in Alzheimer‘s patients for intervention with an antihypertensive drug nilvadipine:results from a 6-week open label study[J].Int J Geriatr Psych,2011,26(10):1038-1045.
  • 9Nakazawa M,Ohguro H,Takeuchi K,et al.Effect of nilvadipine on central visual fi eld in retinitis pigmentosa:a30-month clinical trial[J].Ophthalmologica,2011,225:120-126.
  • 10Hanyu H,Hirao K,Shimizu S,et al.Nilvadipine prevents cognitive decline of patients with mild cognitive impairment[J].Int J Geriatr Psych,2007,12(22):1264-1266.

二级参考文献12

共引文献6

同被引文献11

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部